BullFrog AI vs Incannex Healthcare
BFRG and IXHL side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BFRG and IXHL compare
Incannex Healthcare is the larger company, worth 2.7 times as much as BullFrog AI ($24.2M against $9.0M).
Incannex Healthcare scores higher on the StockData Score (7 against 3 for BullFrog AI), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BFRG | IXHL |
|---|---|---|
| Size and price | ||
| Market cap | $9.0M | $24.2M |
| Share price | $0.488 | $1.93 |
| Change, 1 year | −51.2% | −82.0% |
| Beta (5Y) | 4.87 | 2.26 |
| Employees | 9 | 12 |
| StockData Score | ||
| Total score | 3 | 7 (better) |
| Valuation score | 1 | 1 |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 1 (better) |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/B | 1.3× | 0.4× (better) |
| FCF yield | – | −13.2% |
| Profitability | ||
| Return on equity | −131% | −20.7% (better) |
| Return on invested capital | – | −1945% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −1105.4× | – |
| Current ratio | 10.57 | 67.79 (better) |
| Altman Z-score | 1.34 (better) | 0.11 |
| Piotroski F-score | 2 | 4 (better) |
| Dividends and buybacks | ||
| Buyback yield | −111% | −38.0% (better) |
| Shareholder yield | −111% | −38.0% (better) |
| Ownership | ||
| Held by institutions | 7.5% | 3.6% |
| Held by insiders | 13.7% | – |
| Insider net buying, 12 months | $71.5K | – |
Go deeper
- BFRG stock overview
- BFRG income statement
- BFRG valuation and score
- IXHL stock overview
- IXHL income statement
- IXHL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.